Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With Dexcom [Yahoo! Finance]
Medpace Holdings, Inc. (MEDP)
Last medpace holdings, inc. earnings: 4/28 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.medpace.com
Company Research
Source: Yahoo! Finance
NEW YORK, March 25, 2025 BUSINESS WIRE Nanowear , a leader in home-based cardiometabolic digital diagnostics announced that SimpleSense™, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data from Dexcom G7 Continuous Glucose Monitoring Systems (CGM) time synchronously alongside Nanowear's previously FDA cleared cardiovascular biomarkers. The continuous combination of glucose readings, blood pressure, ECGs, lung volume, respiration and hemodynamics offer unprecedented real-world and real-time cardiometabolic diagnostic assessments to the pharmaceutical, medtech, biotech, contract-research-organization (CRO) and direct-to-consumer (DTC) research communities. "Our Nanowear-Dexcom integration and data partnership will be a unique offering in clinical research," says Venk Varadan, CEO and Co-founder of Nanowear. "With the addition of CGM, our platform of 85+ cardiopulmonary and hemodynamic biomarkers now becomes the first-and-only self-ad
Show less
Read more
Impact Snapshot
Event Time:
MEDP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MEDP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MEDP alerts
High impacting Medpace Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
MEDP
News
- Medpace (NASDAQ:MEDP) had its "underweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- How Medpace's Q3 2025 Surge and Buybacks Strategy Could Impact Medpace Holdings (MEDP) Investors [Yahoo! Finance]Yahoo! Finance
- 2 Profitable Stocks to Keep an Eye On and 1 We Find Risky [Yahoo! Finance]Yahoo! Finance
- Medpace (MEDP): Assessing Valuation After Revenue Growth, Buybacks and AI-Driven Clinical Trial Expansion [Yahoo! Finance]Yahoo! Finance
- Medpace Holdings, Inc. (MEDP): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
MEDP
Earnings
- 10/22/25 - Beat
MEDP
Sec Filings
- 12/9/25 - Form 4
- 12/4/25 - Form 4
- 12/4/25 - Form 4
- MEDP's page on the SEC website